Management of hypertension in the transplant patient

Journal of the American Society of Hypertension

Volumn 5, Issue 5, 2011, Pages 425-432

  Weir, Matthew R ^a   Salzberg, Daniel J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CARVEDILOL; CHLORTALIDONE; CORTICOSTEROID; CYCLOSPORIN; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LABETALOL; LOOP DIURETIC AGENT; METOLAZONE; METOPROLOL; NEBIVOLOL; NICARDIPINE; NONDIHYDROPYRIDINE; PLACEBO; TACROLIMUS; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG; VERAPAMIL;

ACUTE KIDNEY FAILURE; ANEMIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; DIURETIC THERAPY; FATIGUE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; HYPERKALEMIA; HYPERTENSION; INSULIN RESISTANCE; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; METABOLIC DISORDER; NEPHROTOXICITY; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCINEURIN; CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; REGRESSION ANALYSIS; RENAL ARTERY OBSTRUCTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 80052978721     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2011.07.003     Document Type: Article

References (51)

1. J.J. Curtis Cyclosporine and posttransplant hypertension J Am Soc Nephrol 2 1992 S243 S245
2. B.L. Kasiske, S. Anjum, R. Shah, J. Skogen, C. Kandaswamy, and B. Danielson Hypertension after kidney transplantation Am J Kidney Dis 43 2004 1071 1081 (Pubitemid 38691503)
3. R.G. Luke Pathophysiology and treatment of posttransplant hypertension J Am Soc Nephrol 2 1991 S37 S44
4. K. Budde, J. Waiser, L. Fritsche, J. Zitzmann, M. Schreiber, and R. Kunz Hypertension in patients after renal transplantation Transplant Proceed 29 1997 209 211 (Pubitemid 27123378)
5. J.M. Sorof, E.K. Sullivan, A.M.I.R. Tejani, and R.J. Portman Antihypertensive medication and renal allograft failure: a North American Pediatric Renal Transplant Cooperative Study report J Am Soc Nephrol 10 1999 1324 1330 (Pubitemid 29246999)
6. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report JAMA 289 2003 2560 2572 (Pubitemid 37430158)
7. R.G. Luke Pathophysiology and treatment of posttransplant hypertension J Am Soc Nephrol 2 1991 S37 S44
8. C. Ponticelli, G. Montagnino, A. Aroldi, C. Angelini, M. Braga, and A. Tarantino Hypertension after renal transplantation Am J Kidney Dis 21 1993 73 78 (Pubitemid 23158801)
9. A.E. Raine Does antihypertensive therapy modify chronic allograft failure? Kidney Int Suppl 52 1995 S107 S111
10. C.E. Sanders Jr., and J.J. Curtis Role of hypertension in chronic renal allograft dysfunction Kidney Int Suppl 52 1995 S43 S47
11. A. Vianello, S. Mastrosimone, G. Calconi, P.L. Gatti, P. Calzavara, and M.C. Maresca The role of hypertension as a damaging factor for kidney grafts under cyclosporine therapy Am J Kidney Dis 21 1993 79 83 (Pubitemid 23158802)
12. S. Bruno, G. Remuzzi, and P. Ruggenenti Transplant renal artery stenosis J Am Soc Nephrol 15 2004 134 141 (Pubitemid 38028562)
13. G. Conte, C.A. Dal, M. Sabbatini, P. Napodano, N.L. De, and G. Gigliotti Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects Kidney Int 36 1989 1086 1092 (Pubitemid 20049216)
14. J.J. Curtis, R.G. Luke, P. Jones, and A.G. Diethelm Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent Am J Med 85 1988 134 138
15. D.S. Gardiner, M.A. Watson, B.J. Junor, J.D. Briggs, I.A. More, and G.B. Lindop The effect of conversion from cyclosporin to azathioprine on renin-containing cells in renal allograft biopsies Nephrol Dial Transplant 6 1991 363 367
16. V. Kon, M. Sugiura, T. Inagami, B.R. Harvie, I. Ichikawa, and R.L. Hoover Role of endothelin in cyclosporine-induced glomerular dysfunction Kidney Int 37 1990 1487 1491 (Pubitemid 20198030)
17. J.B. Kopp, and P.E. Klotman Cellular and molecular mechanisms of cyclosporin nephrotoxicity J Am Soc Nephrol 1 1990 162 179
18. P.G. McNally, and J. Feehally Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations Nephrol Dial Transplant 7 1992 791 804
19. M. Moran, M.F. Mozes, M.S. Maddux, S. Veremis, C. Bartkus, and B. Ketel Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone N Engl J Med 322 1990 1183 1188 (Pubitemid 20137849)
20. N.G. Moss, S.L. Powell, and R.J. Falk Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats Proc Natl Acad Sci U S A 82 1985 8222 8226 (Pubitemid 16171066)
21. U. Scherrer, S.F. Vissing, B.J. Morgan, J.A. Rollins, R.S. Tindall, and S. Ring Cyclosporine-induced sympathetic activation and hypertension after heart transplantation N Engl J Med 323 1990 693 699 (Pubitemid 20288937)
22. G. Ligtenberg, R.J. Hene, P.J. Blankestijn, and H.A. Koomans Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus J Am Soc Nephrol 12 2001 368 373 (Pubitemid 32116380)
23. A. Oliveras, S. Vazquez, S. Hurtado, J. Vila, J.M. Puig, and J. Lloveras Ambulatory blood pressure monitoring in renal transplant patients: modifiable parameters after active antihypertensive treatment Transplant Proc 36 2004 1352 1354 (Pubitemid 38902975)
24. G.W. Lipkin, B. Tucker, M. Giles, and A.E. Raine Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients J Hypertens 11 1993 439 442 (Pubitemid 23139787)
25. V. Audard, M. Matignon, F. Hemery, R. Snanoudj, P. Desgranges, and M.C. Anglade Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty Am J Transplant 6 2006 95 99 (Pubitemid 43382206)
26. E. Benedetti, C. Troppmann, K. Gillingham, D.E. Sutherland, W.D. Payne, and D.L. Dunn Short- and long-term outcomes of kidney transplants with multiple renal arteries Ann Surg 221 1995 406 414
27. G.M. Baxter, H. Ireland, J.G. Moss, P.N. Harden, B.J. Junor, and R.S. Rodger Colour Doppler ultrasound in renal transplant artery stenosis: which Doppler index? Clin Radiol 50 1995 618 622
28. C.M. Erley, S.H. Duda, J.P. Wakat, M. Sokler, P. Reuland, and W. Muller-Schauenburg Noninvasive procedures for diagnosis of renovascular hypertension in renal transplant recipients - a prospective analysis Transplantation 54 1992 863 867
29. T.C. Leertouwer, and E.J. Gussenhoven van OH, Man in 't Veld AJ, van Jaarsveld BC. Stent placement for treatment of renal artery stenosis guided by intravascular ultrasound J Vasc Interv Radiol 9 1998 945 952 (Pubitemid 28530368)
30. P. Ruggenenti, L. Mosconi, S. Bruno, A. Remuzzi, F. Sangalli, and M.S. Lepre Post-transplant renal artery stenosis: the hemodynamic response to revascularization Kidney Int 60 2001 309 318 (Pubitemid 32587569)
31. F.G. Cosio, R.P. Pelletier, T.E. Pesavento, M.L. Henry, R.M. Ferguson, and L. Mitchell Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients Kidney Int 59 2001 1158 1164 (Pubitemid 32206881)
32. G. Opelz, T. Wujciak, and E. Ritz Association of chronic kidney graft failure with recipient blood pressure Kidney Int 53 1998 217 222 (Pubitemid 28066925)
33. M.R. Weir Blood pressure management in the kidney transplant recipient Adv Chronic Kidney Dis 11 2004 172 183 (Pubitemid 39295211)
34. K.C. Mange, B. Cizman, M. Joffe, and H.I. Feldman Arterial hypertension and renal allograft survival JAMA 283 2000 633 638 (Pubitemid 30069179)
35. J.J. Sennesael, J.G. Lamote, I. Violet, S. Tasse, and D.L. Verbeelen Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients Am J Kidney Dis 27 1996 701 708 (Pubitemid 26135843)
36. J.J. Curtis, D.A. Laskow, P.A. Jones, B.A. Julian, R.S. Gaston, and R.G. Luke Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients J Am Soc Nephrol 3 1993 1570 1574
37. M.R. van der Schaaf, R.J. Hene, M. Floor, P.J. Blankestijn, and H.A. Koomans Hypertension after renal transplantation. Calcium channel or converting enzyme blockade? Hypertension 25 1995 77 81
38. N.C. Premasathian, R. Muehrer, P.C. Brazy, J.D. Pirsch, and B.N. Becker Blood pressure control in kidney transplantation: therapeutic implications J Hum Hypertens 18 2004 871 877 (Pubitemid 39600143)
39. M. Hausberg, M. Barenbrock, H. Hohage, S. Muller, S. Heidenreich, and K.H. Rahn ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients Hypertension 33 1999 862 868 (Pubitemid 29140447)
40. S. Hiremath, D. Fergusson, S. Doucette, A.V. Mulay, and G.A. Knoll Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence Am J Transplant 7 2007 2350 2360 (Pubitemid 47347851)
41. B.F. Palmer Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system N Engl J Med 351 2004 585 592
42. J.J. Curtis, R.G. Luke, J.D. Whelchel, A.G. Diethelm, P. Jones, and H.P. Dustan Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension N Engl J Med 308 1983 377 381 (Pubitemid 13187220)
43. C.E. Stigant, J. Cohen, M. Vivera, and J.S. Zaltzman ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy Am J Kidney Dis 35 2000 58 63 (Pubitemid 30027241)
44. A.E. el-Agroudy, N.A. Hassan, M.A. Foda, A.M. Ismail, E.A. el-Sawy, and O. Mousa Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients Am J Nephrol 23 2003 300 306 (Pubitemid 37116929)
45. P. Inigo, J.M. Campistol, S. Lario, C. Piera, B. Campos, and M. Bescos Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients J Am Soc Nephrol 12 2001 822 827 (Pubitemid 32246711)
46. D. Dragun, D.N. Muller, J.H. Brasen, L. Fritsche, M. Nieminen-Kelha, and R. Dechend Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection N Engl J Med 352 2005 558 569 (Pubitemid 40204669)
47. M.R. Weir Providing end-organ protection with renin-angiotensin system inhibition: the evidence so far J Clin Hypertens (Greenwich) 8 2006 99 105
48. T. Philipp, F. Martinez, H. Geiger, B. Moulin, G. Mourad, and R. Schmieder Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET Nephrol Dial Transplant 25 2010 967 976
49. G. Heinze, C. Mitterbauer, H. Regele, R. Kramar, W.C. Winkelmayer, and G.C. Curhan Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation J Am Soc Nephrol 17 2006 889 899
50. T. Cieciura, G. Senatorski, K. Rell, T. Baczkowska, L. Paczek, and L. Gradowska Influence of angiotensin-converting enzyme inhibitor treatment of the carotid artery intima-media complex in renal allograft recipients Transplant Proc 32 2000 1335 1336
51. E. Paoletti, M. Amidone, P. Cassottana, M. Gherzi, L. Marsano, and G. Cannella Effect of sirolimus on left ventricular hypertrophy in kidney transplant recipients: a 1-year nonrandomized controlled trial Am J Kidney Dis 52 2008 324 330 (Pubitemid 351997440)